Price $5.33 |
Market Cap
134.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.43
|
P/S
5.81
|
Dividend %
-
|
|
P/CF
518.7
|
P/FCF
-
|
Op. Cash Flow
-700
|
FCF
-0.1
|
|
Op. Margin
-23.50%
|
Net Margin
-26.30%
|
ROE
-10.70%
|
ROI
-10.00%
|
|
ROA
-10.20%
|
EPS Growth
-121.10%
|
Current Ratio
14.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Infinity Pharmaceuticals Inc. (INFI) | $1.47 | - | - | 88.2M | Strong Buy |
| Allergan plc (AGN) | $140.20 | - | 2.00% | 47.08B | Strong Buy |
| Natus Medical Inc (BABY) | $26.35 | - | - | 855.4M | Strong Buy |
| TearLab Corp (TEAR) | $0.09 | - | - | 1M | Strong Buy |
| MTBC Inc (MTBC) | $4.99 | - | - | 64.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
